| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | -0.3% |
| R&D Expense | $28.8M | -17.5% |
| SG&A Expense | $32.5M | -1.5% |
| Operating Income | -$59.9M | +9.9% |
| Pre-tax Income | -$60.7M | +27.5% |
| Income Tax | -$537K | — |
| Net Income | -$60.2M | +28.2% |
| EPS (Basic) | -$0.04 | +42.9% |
| EPS (Diluted) | -$0.04 | +42.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.0M | +39.8% |
| Current Assets | $5.5M | +35.8% |
| Total Assets | $81.3M | +204.1% |
| Current Liabilities | $91.7M | +34.3% |
| Long-term Debt | $60.0M | -4.2% |
| Total Liabilities | $128.9M | +21.9% |
| Stockholders' Equity | -$60.3M | +36.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.8M | +21.5% |
| Capital Expenditures | $1.5M | +48.3% |
| Investing Cash Flow | -$1.8M | -79.0% |
| Financing Cash Flow | $49.3M | -13.1% |
| Free Cash Flow | -$46.3M | +20.3% |